Parent and physician perspectives on quality of care at the end of life in children with cancer
- PMID: 16172457
- DOI: 10.1200/JCO.2005.04.010
Parent and physician perspectives on quality of care at the end of life in children with cancer
Abstract
Purpose: To ascertain parents' and physicians' assessments of quality of end-of-life care for children with cancer and to determine factors associated with high-quality care as perceived by parents and physicians.
Methods: A survey was conducted between 1997 and 2001 of 144 parents of children who received treatment at the Dana-Farber Cancer Institute and Children's Hospital (Boston, MA) or Children's Hospitals and Clinics of St Paul and Minneapolis, MN, between 1990 and 1999 (65% of those located and eligible) and 52 pediatric oncologists.
Results: In multivariable models, higher parent ratings of physician care were associated with physicians giving clear information about what to expect in the end-of-life period (odds ratio [OR] = 19.90, P = .02), communicating with care and sensitivity (OR = 7.67, P < .01), communicating directly with the child when appropriate (OR = 11.18, P < .01), and preparing the parent for circumstances surrounding the child's death (OR = 4.84, P = .03). Parent reports of the child's pain and suffering were not significant correlates of parental ratings of care (P = .93 and .35, respectively). Oncologists' ratings of care were inversely associated with the parent's report of the child's experience of pain (OR = 0.15, P = .01) and more than 10 hospital days in the last month of life (OR = 0.24, P < .01). Parent-rated communication factors were not correlates of oncologist-rated care. No association was found between parent and physician care ratings (P = .88).
Conclusion: For parents of children who die of cancer, doctor-patient communication is the principal determinant of high-quality physician care. In contrast, physicians' care ratings depend on biomedical rather than relational aspects of care.
Comment in
-
Pediatric palliative care: relationships matter and so does pain control.J Clin Oncol. 2005 Dec 20;23(36):9055-7. doi: 10.1200/JCO.2005.04.4677. Epub 2005 Nov 28. J Clin Oncol. 2005. PMID: 16314610 No abstract available.
Similar articles
-
Hope and prognostic disclosure.J Clin Oncol. 2007 Dec 10;25(35):5636-42. doi: 10.1200/JCO.2007.12.6110. J Clin Oncol. 2007. PMID: 18065734
-
Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer.Klin Padiatr. 2008 May-Jun;220(3):166-74. doi: 10.1055/s-2008-1065347. Klin Padiatr. 2008. PMID: 18478489
-
Symptoms and suffering at the end of life in children with cancer.N Engl J Med. 2000 Feb 3;342(5):326-33. doi: 10.1056/NEJM200002033420506. N Engl J Med. 2000. PMID: 10655532
-
Palliative care in children with cancer: which child and when?J Natl Cancer Inst Monogr. 2004;(32):144-9. doi: 10.1093/jncimonographs/lgh007. J Natl Cancer Inst Monogr. 2004. PMID: 15263058 Review.
-
Integrative review: parent perspectives on care of their child at the end of life.J Pediatr Nurs. 2012 Oct;27(5):514-22. doi: 10.1016/j.pedn.2011.07.008. Epub 2011 Sep 13. J Pediatr Nurs. 2012. PMID: 22920662 Review.
Cited by
-
Life and Death: A Multicenter Study Evaluating Cardiologists' Approach to Difficult Conversations with Fontan Patients and Families.Pediatr Cardiol. 2024 Aug 20. doi: 10.1007/s00246-024-03631-5. Online ahead of print. Pediatr Cardiol. 2024. PMID: 39164409
-
Attachment as a mechanism influencing end-of-life communication: An analogue investigation.PLoS One. 2024 Jul 31;19(7):e0303652. doi: 10.1371/journal.pone.0303652. eCollection 2024. PLoS One. 2024. PMID: 39083512 Free PMC article.
-
How Good Are Cardiologists at Predicting Major Adverse Events in Fontan Patients?JACC Adv. 2023 Nov 24;3(1):100736. doi: 10.1016/j.jacadv.2023.100736. eCollection 2024 Jan. JACC Adv. 2023. PMID: 38939804 Free PMC article.
-
Developing online communication training to request donation for vascularized composite allotransplantation (VCA): improving performance to match new US organ donation targets.BMC Med Educ. 2024 Jan 22;24(1):77. doi: 10.1186/s12909-024-05026-9. BMC Med Educ. 2024. PMID: 38254115 Free PMC article.
-
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity.Front Immunol. 2023 Aug 14;14:1225610. doi: 10.3389/fimmu.2023.1225610. eCollection 2023. Front Immunol. 2023. PMID: 37646042 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
